Dose Response Study of Patients With Erythematous Rosacea

Completed · Phase 2

Conditions studied: Erythematous (Type One) Rosacea

In brief

The purpose of this study is to evaluate the dose-response relationship (effect) of four concentrations of V-101 Cream in patients with erythematous(redness) rosacea.

Key facts

Study ID

NCT01186068

Run by

Vicept Therapeutics, Inc.

People needed

175

Starts

2010-08-01

Last updated by the study team

2010-11-24

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• male or females at least 18 years of age
• diagnosis of stable erythematous rosacea
• < 3 inflammatory lesions
• in good general health
• females must be non-pregnant and non-lactating
• must be willing to sign a consent form

You may not qualify if…

• have ocular, phymatous or other types of rosacea
• allergy to any ingredient in study drug
• participation in other investigational studies within 30 days of enrollment
• use of systemic steroids within 28 days of Baseline
• use of tetracycline antibiotics within 28 days of baseline
• use of products containing oxymetazoline within 14 days of baseline
• use of topical steroids witin treatment area 14 days prior to baseline
• use of Rx or OTC products for treatment of acne or rosacea within 14 days of baseline
• use of any product for reducing redness within the treatment area witin 14 days prior to baseline
• use of monoamine oxidase (MAO) inhibitors
• use of niacin >/= 500mg/day

Where it is running

• Therapeutics Clinical Research — San Diego, California, United States
• Baumann Cosmetic & Research Institute — Miami Beach, Florida, United States
• Dermatology Specialists Research — Louisville, Kentucky, United States
• DBA Michigan Center for Skin Care Research — Clinton Twp, Michigan, United States
• Academic Dermatology Associates — Albuquerque, New Mexico, United States
• Oregon Medical Research Center, PC — Portland, Oregon, United States
• DermResearch, Inc. — Austin, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.